SYBX Synlogic Corp: Accounting Value per Share

Graphic logo of Synlogic (SYBX)

Synlogic, Inc. (SYBX) derives its reliability from unique patents in the field of synthetic biology. Analyzing the consolidated balance sheet value of the stock on GURU.Markets, we see confirmation of the capitalization, where the current level is approximately 0.89. Growth prospects are based on the monetization of intellectual property and M&A transactions. Business stability is further complemented by low geopolitical risk due to the protection of rights in the US and EU.

Synlogic Corp (SYBX): Share Book Value from 07/04/2022 to 01/24/2026
Manufactured products of Synlogic Corp

To protect their capital, investors select assets with a sustainable net asset margin, which is critical for Synlogic, Inc. (SYBX), as its value is based on a unique scientific platform and a staff of synthetic biology experts. When analyzing the historical trend of the stock's book value, one should evaluate the remaining equity per share after deducting liabilities, which determines the business's actual asset base.

Competitors of Synlogic, Inc. (SYBX)

ASND - Book Value per Share|Madrigal Corp (MDGL) - Net Assets per Single Share|Accounting Value per Share Corcept Therapeutics|RYTM (rhythmtx.com) - Equity per Share|Net Assets per Single Share Akero AKRO|Share Book Value Metsera, Inc.|MoonLake Pharma (MLTX) - Book Value per Share|Accounting Value of a Share Crinetics Corp (CRNX)|Book Value per Share NAMS (NewAmsterdam Pharma)|soleno.life - Book Value per Share|Net Assets per Single Share Amicus Therapeutics, Inc. (FOLD)|ETNB: Accounting Value of a Share|AGIO (Agios Pharmaceuticals Inc) - Net Assets per Single Share|Structure Corp (GPCR) - Accounting Value per Share|MDXG (MiMedx Group, Inc.) - Book Value per Share|Book Value per Share rezolutebio.com (RZLT)|Lexicon Pharmaceuticals, Inc. (LXRX) - Accounting Value per Share|Accounting Value of a Share MBX (MBX Biosciences, Inc.)|Altimmune Corp - Net Assets per Single Share|Accounting Value per Share Aardvark Pharma AARD|SGMT (Sagimet Biosciences) - Book Value per Share|bioagelabs.com (BIOA) - Net Asset Value per Share|BMEA - Accounting Value per Share|Quince Therapeutics, Inc. (QNCX) - Book Price of a Share|GUTS (Fractyl) - Book Value per Share|Book Value per Share vTv Therapeutics Inc|Book Value per Share Agape ATP Corporation (ATPC)|Net Assets per Single Share PLUR (pluri-biotech.com)|LPCN: Net Assets per Single Share|Matinas BioPharma Holdings, Inc. - Net Asset Value per Share|SPRB - Net Assets per Single Share|GLTO - Net Assets per Single Share|Carmell Corporation - Book Value per Share|LUMO (lumos-pharma.com) - Net Assets per Share|ONVO: Net Assets per Single Share|Net Assets per Share RDUS